Jinshi Asia Pharmaceutical: Report for the third quarter of 2024

SZSIOct 23 12:00 ET · Announcements

Some Shareholders Feeling Restless Over Sichuan Goldstone Asia Pharmaceutical Inc.'s (SZSE:300434) P/S Ratio

Simply Wall StOct 3 01:41 ET

Sichuan Goldstone (300434.SZ): Does not involve the production of PBO materials

Goldstone Pharmaceuticals (300434.SZ) stated on the investor interaction platform on September 12 that the company is not involved in the production of PBO materials and is currently conducting research and development work on vacuum coating equipment for the surface metallization treatment of PBO materials.

Gelonghui FinanceSep 12 05:12 ET

We Think You Can Look Beyond Sichuan Goldstone Asia Pharmaceutical's (SZSE:300434) Lackluster Earnings

Simply Wall StSep 4 18:51 ET

Jinshi Asia Pharmaceutical: 2024 Semi-Annual Report Summary

SZSIAug 28 12:00 ET · Announcements

Jinshi Asia Pharmaceutical: 2024 Semi-Annual Report

SZSIAug 28 12:00 ET · Announcements